the crucial function of circSLC25A16 on NSCLC glycolysis through miR-488-3p/HIF-1alpha/LDHA, suggesting the underlying pathogenesis for NSCLC and providing a therapeutic strategy for precise treatment.
Circular RNA circSLC25A16 contributes to the glycolysis of non-small-cell lung cancer through epigenetic modification.